Obtaining funding for this kind of experiments is often a obstacle—the stigmatization of psilocybin has prompted governmental funding bodies in order to avoid assignments involving the compound. Even so, Nichols thinks that, as trials demonstrating the possible benefits of psilocybin continue to kee